TUMOUR PSEUDOPROGRESSION

This adverse event was reported 1095 times

These drugs are most commonly taken by patients reporting TUMOUR PSEUDOPROGRESSION:

# Drug Count
0 PEMBROLIZUMAB 475
1 NIVOLUMAB 191
2 TEMOZOLOMIDE 186
3 CARBOPLATIN 99
4 IPILIMUMAB 84
5 PEMETREXED DISODIUM 65
6 PACLITAXEL 58
7 PACLITAXEL (AIBUMIN-BOUND) 52
8 PEMETREXED 51
9 CISPLATIN 45
See all common drugs associated with TUMOUR PSEUDOPROGRESSION